These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 39318272

  • 1. Characterization of hypofibrinogenemia following rattlesnake envenomation treated with crotalidae immune F(ab')2 (equine) antivenom.
    Maciulewicz TS, Axon DR, Shirazi FM.
    Clin Toxicol (Phila); 2024 Nov; 62(11):749-753. PubMed ID: 39318272
    [Abstract] [Full Text] [Related]

  • 2. Late hemotoxicity following North American rattlesnake envenomation treated with crotalidae immune F(ab')2 (equine) antivenom and crotalidae immune polyvalent Fab (ovine) antivenom reported to the North American Snakebite Sub-registry.
    Spyres MB, Padilla GK, Gerkin RD, Hoyte CO, Wolk BJ, Ruha AM, ToxIC Snakebite Study Group.
    Clin Toxicol (Phila); 2022 Jul; 60(7):838-842. PubMed ID: 35261320
    [Abstract] [Full Text] [Related]

  • 3. Fashionably late: A characterization of late coagulopathies in rattlesnake envenomations between Fab and F(ab')2 antivenoms.
    Dudley S, Smelski G, Massey DJ, Maciulewicz T, Cardwell MD, Shirazi FM.
    Toxicon; 2022 Jun; 212():49-54. PubMed ID: 35413335
    [Abstract] [Full Text] [Related]

  • 4. Early Experience with Crotalidae Immune F(ab')2 Antivenom to Treat Arizona Rattlesnake Envenomations.
    Ruha AM, Padilla-Jones A, Canning J, Spyres MB, Curry SC.
    J Med Toxicol; 2022 Jan; 18(1):38-42. PubMed ID: 34665424
    [Abstract] [Full Text] [Related]

  • 5. Use of both Fab and F(ab')2 fragment antivenom in a pediatric patient for treatment of a North American Crotalidae envenomation.
    Martin AM, Wang GS, Poel K.
    Am J Emerg Med; 2021 Jul; 45():677.e1-677.e3. PubMed ID: 33293188
    [Abstract] [Full Text] [Related]

  • 6. Use of Crotalidae equine immune F(ab')2 antivenom for treatment of an Agkistrodon envenomation.
    Wilson BZ, Larsen J, Smelski G, Dudley S, Shirazi FM.
    Clin Toxicol (Phila); 2021 Nov; 59(11):1023-1026. PubMed ID: 33703984
    [Abstract] [Full Text] [Related]

  • 7. Subacute coagulopathy in a randomized, comparative trial of Fab and F(ab')2 antivenoms.
    Boyer LV, Chase PB, Degan JA, Figge G, Buelna-Romero A, Luchetti C, Alagón A.
    Toxicon; 2013 Nov; 74():101-8. PubMed ID: 23948058
    [Abstract] [Full Text] [Related]

  • 8. Pediatric Rattlesnake Envenomations Treated With Crotalidae Equine Immune F(Ab') 2 Antivenom : A 3-Year Retrospective Observational Analysis.
    Seltzer JA, Winkler GA, Friedman NA, Galust H, Hardin J, Srihari P, Ontiveros S, Corbett B, Clark RF.
    Pediatr Emerg Care; 2023 Oct 01; 39(10):776-779. PubMed ID: 37725768
    [Abstract] [Full Text] [Related]

  • 9. Thromboelastography with Platelet Studies (TEG® with PlateletMapping®) After Rattlesnake Envenomation in the Southwestern United States Demonstrates Inhibition of ADP-Induced Platelet Activation As Well As Clot Lysis.
    Kang AM, Fisher ES.
    J Med Toxicol; 2020 Jan 01; 16(1):24-32. PubMed ID: 31407209
    [Abstract] [Full Text] [Related]

  • 10. Failure of Crotalidae Immune F(ab')2 Equine Antivenom to Achieve Control in a Southern Pacific Rattlesnake Envenomation.
    Levine M, Spungen H, Pizon AF.
    Ann Emerg Med; 2022 Dec 01; 80(6):525-527. PubMed ID: 35953386
    [Abstract] [Full Text] [Related]

  • 11. Initial Experience with F(ab')2 Antivenom Compared with Fab Antivenom for Rattlesnake Envenomations Reported to a single poison center during 2019.
    Wilson BZ, Bahadir A, Andrews M, Karpen J, Winkler G, Smelski G, Dudley S, Walter FG, Shirazi FM.
    Toxicon; 2022 Apr 15; 209():10-17. PubMed ID: 35085602
    [Abstract] [Full Text] [Related]

  • 12. Comparison of F(ab')2 and Fab antivenoms in rattlesnake envenomation: First year's post-marketing experience with F(ab')2 in New Mexico.
    Mascarenas DN, Fullerton L, Smolinske SC, Warrick BJ, Seifert SA.
    Toxicon; 2020 Oct 30; 186():42-45. PubMed ID: 32763251
    [Abstract] [Full Text] [Related]

  • 13. Unpredicted late-, new-onset thrombocytopenia and hypofibrinogenemia in Fab antivenom-treated rattlesnake envenomation.
    Seifert SA, Mascarenas DN, Fullerton L, Warrick BJ, Smolinske SC.
    Toxicon; 2020 Sep 30; 184():55-56. PubMed ID: 32505639
    [Abstract] [Full Text] [Related]

  • 14. Acute adverse effects of F(ab')₂AV and FabAV use for rattlesnake Envenomations: A four-year poison center study.
    Seltzer JA, Winkler GA, Hardin J, Galust H, Albertson TE, Vohra R, Smollin C, Castillo E, Lasoff D, Clark RF.
    Am J Emerg Med; 2025 Jan 30; 87():28-31. PubMed ID: 39454230
    [Abstract] [Full Text] [Related]

  • 15. A new F(ab')2 antivenom for the treatment of crotaline envenomation in children.
    Lasoff DR, Ruha AM, Curry SC, Koh C, Clark RF.
    Am J Emerg Med; 2016 Oct 30; 34(10):2003-2006. PubMed ID: 27567423
    [Abstract] [Full Text] [Related]

  • 16. 272 cases of rattlesnake envenomation in dogs: Demographics and treatment including safety of F(ab')2 antivenom use in 236 patients.
    Witsil AJ, Wells RJ, Woods C, Rao S.
    Toxicon; 2015 Oct 30; 105():19-26. PubMed ID: 26341419
    [Abstract] [Full Text] [Related]

  • 17. Comparison of F(ab')2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trial.
    Bush SP, Ruha AM, Seifert SA, Morgan DL, Lewis BJ, Arnold TC, Clark RF, Meggs WJ, Toschlog EA, Borron SW, Figge GR, Sollee DR, Shirazi FM, Wolk R, de Chazal I, Quan D, García-Ubbelohde W, Alagón A, Gerkin RD, Boyer LV.
    Clin Toxicol (Phila); 2015 Jan 30; 53(1):37-45. PubMed ID: 25361165
    [Abstract] [Full Text] [Related]

  • 18. Continuous IV Crotalidae Polyvalent Immune Fab (Ovine) (FabAV) for selected North American rattlesnake bite patients.
    Bush SP, Seifert SA, Oakes J, Smith SD, Phan TH, Pearl SR, Reibling ET.
    Toxicon; 2013 Jul 30; 69():29-37. PubMed ID: 23474267
    [Abstract] [Full Text] [Related]

  • 19. Rattlesnake venom-induced recurrent coagulopathy in first trimester pregnant women - Two Cases.
    Moore EC, Porter LM, Ruha AM.
    Toxicon; 2019 May 30; 163():8-11. PubMed ID: 30880187
    [Abstract] [Full Text] [Related]

  • 20. Coagulation parameters in copperhead compared to other Crotalinae envenomation: secondary analysis of the F(ab')2 versus Fab antivenom trial.
    Gerardo CJ, Vissoci JR, Brown MW, Bush SP.
    Clin Toxicol (Phila); 2017 Feb 30; 55(2):109-114. PubMed ID: 27806644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.